Preventing transmission of human immunodeficiency virus type1 (HIV-1) and caring for those already infected are essentialservices in any comprehensive program, and enhancing the mutuallybeneficial effect of each is an international goal.1 These reinforcingeffects are clearly illustrated in the two articles from thePerinatal HIV Prevention Trial (PHPT) Group in this issue ofthe Journal. The first report, by Lallemant et al., demonstratesthe considerable efficacy of a dual antiretroviral regimen inreducing mother-to-child transmission of HIV-1,2 whereas thesecond, by Jourdain et al., evaluates the effects of subsequentprovision of highly active antiretroviral therapy (HAART) . . . [Full Text of this Article]
Source Information
From the Nelson Mandela School of Medicine, University of Kwazulu/Natal, Durban, South Africa.
This article has been cited by other articles:
Onen, N. F., Nurutdinova, D., Sungkanuparph, S., Gase, D., Mondy, K., Overton, E. T.
(2008). Effect of Postpartum HIV Treatment Discontinuation on Long-Term Maternal Outcome. J Int Assoc Physicians AIDS Care (Chic Ill)
7: 245-251
[Abstract]
Klimas, N., Koneru, A. O., Fletcher, M. A.
(2008). Overview of HIV. Psychosom. Med.
70: 523-530
[Abstract][Full Text]
Lalonde, M. S., Troyer, R. M., Syed, A. R., Bulime, S., Demers, K., Bajunirwe, F., Arts, E. J.
(2007). Sensitive Oligonucleotide Ligation Assay for Low-Level Detection of Nevirapine Resistance Mutations in Human Immunodeficiency Virus Type 1 Quasispecies. J. Clin. Microbiol.
45: 2604-2615
[Abstract][Full Text]
Hinds, J, Dixon, T, Dix, D
(2005). A strategy to minimise the impact of maternal HIV. Arch. Dis. Child.
90: 1319-1319
[Full Text]
Shetty, A. K., Maldonado, Y.
(2005). Advances in the Prevention of Perinatal HIV-1 Transmission. NeoReviews
6: e12-e25
[Full Text]